TY - JOUR
T1 - Relation of serum retinol to acute phase proteins and malarial morbidity in Papua New Guinea children
AU - Rosales, Francisco J.
AU - Topping, James D.
AU - Smith, John E.
AU - Shankar, Anu H.
AU - Ross, A. Catharine
PY - 2000/6
Y1 - 2000/6
N2 - Background: Acute phase proteins (APPs) are associated with malaria- induced hyporetinemia (serum retinol <0.70 μmol/L); however, the degree of the association is not well documented. Objective: The association between malaria-induced hyporetinemia and APPs was assessed. Design: In a cross- sectional study, 90 children with serum retinol concentrations from <0.35 to >1.05 μmol/L were selected from children in a clinical trial of vitamin A supplementation. Serum was collected before treatment allocation. Retinol binding protein (RBP) concentrations were determined by radioimmunoassays, and transthyretin, α1-acid glycoprotein (AGP), α1-antichymotrypsin, C- reactive protein (CRP), haptoglobin, and albumin concentrations by radial immunodiffusion assays. Results: Children in the subsample had high rates of splenomegaly and Plasmodium-positive blood-smear slides (P < 0.01); AGP (Pearson's r = -0.40, P < 0.001) and CRP (r = -0.21, P = 0.04) were inversely correlated with retinol. The negative APPs RBP, transthyretin, and albumin were positively and significantly associated with retinol. All APPs, except β1-antichymotrypsin, were significantly correlated with splenomegaly. Of the positive APPs, AGP correlated with CRP (r = 0.37, P < 0.001), indicating chronic inflammation. In a stepwise regression analysis, 73% of retinol's variability was explained by RBP and transthyretin. The model predicted that a 1-SD increase in RBP or transthyretin increases retinol by ≃0.38 or 0.47 μmol/L, respectively, whereas an equivalent increase in AGP decreases retinol by 0.12 μmol/L Conclusions: The RBP-transthyretin transport complex of retinol is not altered by inflammation. Positive APPs are useful markers of type and severity of inflammation; however, except for AGP, it is unlikely that they can correct for malaria-induced hyporetinemia.
AB - Background: Acute phase proteins (APPs) are associated with malaria- induced hyporetinemia (serum retinol <0.70 μmol/L); however, the degree of the association is not well documented. Objective: The association between malaria-induced hyporetinemia and APPs was assessed. Design: In a cross- sectional study, 90 children with serum retinol concentrations from <0.35 to >1.05 μmol/L were selected from children in a clinical trial of vitamin A supplementation. Serum was collected before treatment allocation. Retinol binding protein (RBP) concentrations were determined by radioimmunoassays, and transthyretin, α1-acid glycoprotein (AGP), α1-antichymotrypsin, C- reactive protein (CRP), haptoglobin, and albumin concentrations by radial immunodiffusion assays. Results: Children in the subsample had high rates of splenomegaly and Plasmodium-positive blood-smear slides (P < 0.01); AGP (Pearson's r = -0.40, P < 0.001) and CRP (r = -0.21, P = 0.04) were inversely correlated with retinol. The negative APPs RBP, transthyretin, and albumin were positively and significantly associated with retinol. All APPs, except β1-antichymotrypsin, were significantly correlated with splenomegaly. Of the positive APPs, AGP correlated with CRP (r = 0.37, P < 0.001), indicating chronic inflammation. In a stepwise regression analysis, 73% of retinol's variability was explained by RBP and transthyretin. The model predicted that a 1-SD increase in RBP or transthyretin increases retinol by ≃0.38 or 0.47 μmol/L, respectively, whereas an equivalent increase in AGP decreases retinol by 0.12 μmol/L Conclusions: The RBP-transthyretin transport complex of retinol is not altered by inflammation. Positive APPs are useful markers of type and severity of inflammation; however, except for AGP, it is unlikely that they can correct for malaria-induced hyporetinemia.
UR - http://www.scopus.com/inward/record.url?scp=0034130110&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034130110&partnerID=8YFLogxK
U2 - 10.1093/ajcn/71.6.1582
DO - 10.1093/ajcn/71.6.1582
M3 - Article
C2 - 10837302
AN - SCOPUS:0034130110
SN - 0002-9165
VL - 71
SP - 1582
EP - 1588
JO - American Journal of Clinical Nutrition
JF - American Journal of Clinical Nutrition
IS - 6
ER -